UNSPSC 51386101: Exisulind

This classification denotes a cyclooxygenase inhibitor with the molecular formula C20H17FO4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K619IIG2R9, chemically known as 1h-indene-3-acetic acid, 5-fluoro-2-methy l-1-((4-(methylsulfonyl)phenyl)methylene)- but generally known as exisulind, which bears US NIH Compound Identifier 5472495. The term EXISULIND is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). Most nations schedule exisulind under HS 29309085 and SITC 51549.

As of Q4 2014, EXISULIND remains the US FDA Preferred Term for this commodity. Exisulind bears US NLM identifiers UMLS ID C0075616 and NCI Concept Code C1239. SMILES: CC\1=C(C2=C(/C1=C\C3=CC=C(C=C3)S(=O)(=O)C)C=CC(=C2)F)CC(=O)O.

UNSPSC 51386101 Exisulind is a Commodity code nominally tied to pharmaceutical products, but recent state and local procurement activity under this code shows a significant mismatch with the abstract classification. Seminole County, Florida's competitive IFB for naloxone and safe drug deactivation systems—posted June 30, 2026, with response due July 26, 2023—represents the available recent opportunity, and the scope centers on public health supply procurement rather than the specific pharmaceutical compound the code name implies. State and local buyers using this code are primarily county health departments and community health agencies seeking to support opioid-crisis response and harm-reduction initiatives through annual supply contracts. The Seminole County opportunity calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building. Vendors must include all shipping and delivery costs, maintain workers' compensation and commercial general liability insurance, comply with E-Verify requirements, and agree to a two-year initial term with one-year renewal option and a three-month probationary period allowing termination at will.

Geographic activity under this code centers on Florida, with the Seminole County solicitation as the only recent opportunity on file. The procurement may draw FEMA funding and subjects contractors to federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. Bidders submit electronically through the county's e-Procurement Portal, with unit pricing for each line item required and no explicit set-aside designations noted. The code shows sparse recent activity; the single available opportunity does not clearly align with the nominal pharmaceutical product scope, suggesting either limited state and local demand for this specific compound or systematic miscoding of health-supply procurements under this category.